Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ihhwa Kim"'
Autor:
Hiroyuki Muranushi, Junya Kanda, Masayuki Kobayashi, Takeshi Maeda, Toshiyuki Kitano, Masaaki Tsuji, Yasunori Ueda, Takayuki Ishikawa, Masaharu Nohgawa, Mitsumasa Watanabe, Kazunori Imada, Toshinori Moriguchi, Mitsuru Itoh, Hitoshi Ohno, Akihito Yonezawa, Hirokazu Hirata, Nobuyoshi Arima, Kohsuke Asagoe, Naoyuki Anzai, Kayoko Nagata, Shinji Yasuno, Yoshihiro Kuwabara, Hiromi Kitao, Ihhwa Kim, Kiyomi Kawagishi, Kenji Ueshima, Shinjiro Tominari, Takeo Nakayama, Kouhei Yamashita, Akifumi Takaori-Kondo
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 239-248 (2022)
Objectives: We conducted a phase II trial to prospectively evaluate the efficacy and safety of bortezomib-cyclophosphamide-dexamethasone (VCD) induction, autologous stem cell transplantation (ASCT), VCD consolidation, and bortezomib maintenance in tr
Externí odkaz:
https://doaj.org/article/be9c1f85b3ab4539bb46b8a6ed1b4f86
Autor:
Junya Kanda, Hiromi Kitao, Masaaki Tsuji, Kazunori Imada, Kosuke Asagoe, Kouhei Yamashita, Toshinori Moriguchi, Ihhwa Kim, Mitsumasa Watanabe, Kenji Ueshima, Masaharu Nohgawa, Akifumi Takaori-Kondo, Yasunori Ueda, Toshiyuki Toshiyuki, Shinji Yasuno, Takayuki Ishikawa, Mitsuru Itoh, Masayuki Kobayashi, Yoshihiro Kuwabara, Takeo Nakayama, Tatsuharu Ohno, Takeshi Maeda, Nobuyoshi Arima, Shinjiro Tominari, Hitoshi Ohno, Hirokazu Hirata, Naoyuki Anzai, Akihito Yonezawa, Kiyomi Kawagishi
Publikováno v:
Blood. 132:3305-3305
Background: Three drug combinations are the standard treatment for newly diagnosed multiple myeloma (NDMM). However, induction, consolidation, and maintenance therapy have not been standardized in Japan. Therefore, in this single arm Phase II study,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9982255de2a053cd2b5d951df2108ce5
https://doi.org/10.1182/blood-2018-99-113816
https://doi.org/10.1182/blood-2018-99-113816